Therapeutic Efficacy of Medicinal Plants with Allopathic Medicine in Musculoskeletal Diseases
Authors:
Open Access
- 1 January 2024
- journal article
- Published by Fortune Journals in International Journal of Plant, Animal and Environmental Sciences
- Vol. 14 (4) , 104-129
Abstract
Musculoskeletal diseases encompass a diverse array of disorders affecting the muscles, bones, joints, and connective tissues, leading to significant impairments in mobility, function, and quality of life. Affecting over 1.3 billion individuals globally, musculoskeletal diseases represent a major source of disability and economic burden. Conventional treatment modalities, including pharmacological interventions and surgical procedures, are frequently limited by adverse side effects, prolonged recovery periods, and patient dissatisfaction, particularly when focused solely on symptom management. In response, complementary and alternative medicine, particularly the use of medicinal plants, has garnered increasing interest to enhance the management of musculoskeletal diseases. Medicinal plants possess a wide spectrum of pharmacologically active compounds with anti-inflammatory, analgesic, and antioxidant properties, making them promising adjuncts to conventional therapies. This review critically evaluates the potential synergy between medicinal plants and allopathic medicine for the management of musculoskeletal diseases, with an emphasis on integrated therapy that combines both modalities. Specifically, a critical discussion is presented on how medicinal plants with scientifically supported pharmacological properties can augment the therapeutic efficacy of conventional medications, reduce their doses, and mitigate adverse effects. Furthermore, the challenges associated with incorporating herbal medicine into established healthcare systems are discussed, including the need for rigorous clinical validation, standardization, and regulatory frameworks. Overall, the article underscores the potential of integrated therapeutic approaches to improve clinical outcomes, enhance patient well-being, and establish a more sustainable model for the treatment of musculoskeletal diseases.Keywords
This publication has 192 references indexed in Scilit:
- Paget disease of boneJournal of Clinical Investigation, 2005
- Corticosteroid injections for trochanteric bursitis: is fluoroscopy necessary? A pilot study †British Journal of Anaesthesia, 2005
- SKELETAL MUSCLE FUNCTION: ROLE OF IONIC CHANGES IN FATIGUE, DAMAGE AND DISEASEClinical and Experimental Pharmacology and Physiology, 2004
- Comparative efficacy and safety of skeletal muscle relaxants for spasticity and musculoskeletal conditions: a systematic reviewJournal of Pain and Symptom Management, 2004
- Effect of St John's Wort on Drug Metabolism by Induction of Cytochrome P450 3A4 EnzymeJAMA, 2003
- Herbal medication: potential for adverse interactions with analgesic drugsJournal of Clinical Pharmacy and Therapeutics, 2002
- Nonsteroidal Anti-Inflammatory Drugs, Acetaminophen, Cyclooxygenase 2, and FeverClinical Infectious Diseases, 2000
- Phosphorylation of dystrophin and α-syntrophin by Ca2+-calmodulin dependent protein kinase IIBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 1999
- Corticosteroids in rheumatoid arthritisBMJ, 1998
- Regulation of Tissue Inhibitor of Metalloproteinases-3 Gene Expression by Transforming Growth Factor-β and Dexamethasone in Bovine and Human Articular ChondrocytesDNA and Cell Biology, 1996